| Descriptor English: | Nimodipine | ||||||
| Descriptor Spanish: |
Nimodipina
| ||||||
| Descriptor Portuguese: | Nimodipina | ||||||
| Descriptor French: | Nimodipine | ||||||
| Entry term(s): |
Admon Bay e 9736 Bayvit, Nimodipino Brainal Calnit Hexal, Nimodipin Kenesil Modus Nimodipin Hexal Nimodipin ISIS Nimodipin-ISIS Nimodipino Bayvit Nimotop Nymalize Remontal e 9736, Bay |
||||||
| Tree number(s): |
D03.383.725.203.570 D03.383.725.547.570 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D009553 | ||||||
| Scope note: | A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Antihypertensive Agents Antihipertensivos Anti-Hipertensivos Antihypertenseurs antihipertensivos Calcium Channel Blockers Bloqueadores de los Canales de Calcio Bloqueadores dos Canais de Cálcio Inhibiteurs des canaux calciques bloqueantes de los canales del calcio Vasodilator Agents Vasodilatadores Vasodilatadores Vasodilatateurs vasodilatadores |
||||||
| Registry Number: | 57WA9QZ5WH | ||||||
| CAS Type 1 Name: | 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester | ||||||
| Previous Indexing: |
Nicotinic Acids (1966-1986) |
||||||
| Public MeSH Note: | 87; NIMODIPINE was indexed under NICOTINIC ACIDS 1981-86 |
||||||
| History Note: | 87; use NIMODIPINE (NM) 1981-86 |
||||||
| DeCS ID: | 23510 | ||||||
| Unique ID: | D009553 | ||||||
| NLM Classification: | QV 150 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1987/01/01 | ||||||
| Date of Entry: | 1986/06/03 | ||||||
| Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
|
Nimodipine
- Preferred
Bay e 9736
- Narrower
Brainal
- Narrower
Calnit
- Narrower
Kenesil
- Narrower
Nymalize
- Narrower
Nimodipin Hexal
- Narrower
Nimodipin-ISIS
- Narrower
Nimodipino Bayvit
- Narrower
Nimotop
- Narrower
Remontal
- Narrower
Admon
- Narrower
Modus
- Narrower
| Concept UI |
M0014859 |
| Scope note | A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure. |
| Preferred term | Nimodipine |
| Concept UI |
M0332201 |
| Preferred term | Bay e 9736 |
| Entry term(s) |
e 9736, Bay |
| Concept UI |
M0463281 |
| Preferred term | Brainal |
| Concept UI |
M0463282 |
| Preferred term | Calnit |
| Concept UI |
M0463283 |
| Preferred term | Kenesil |
| Concept UI |
M0584781 |
| Preferred term | Nymalize |
| Concept UI |
M0463284 |
| Preferred term | Nimodipin Hexal |
| Entry term(s) |
Hexal, Nimodipin |
| Concept UI |
M0463285 |
| Preferred term | Nimodipin-ISIS |
| Entry term(s) |
Nimodipin ISIS |
| Concept UI |
M0463286 |
| Preferred term | Nimodipino Bayvit |
| Entry term(s) |
Bayvit, Nimodipino |
| Concept UI |
M0014860 |
| Preferred term | Nimotop |
| Concept UI |
M0463287 |
| Preferred term | Remontal |
| Concept UI |
M0463280 |
| Preferred term | Admon |
| Concept UI |
M0463288 |
| Preferred term | Modus |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
